Land: Europäische Union
Sprache: Englisch
Quelle: EMA (European Medicines Agency)
Naloxone hydrochloride dihydrate
Mundipharma Corporation (Ireland) Limited
V03AB15
naloxone
All other therapeutic products
Opioid-Related Disorders
Nyxoid is intended for immediate administration as emergency therapy for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in both non-medical and healthcare settings.Nyxoid is indicated in adults and adolescents aged 14 years and over.Nyxoid is not a substitute for emergency medical care.
Revision: 8
Authorised
2017-11-09
21 B. PACKAGE LEAFLET 22 PACKAGE LEAFLET: INFORMATION FOR THE USER NYXOID 1.8 MG NASAL SPRAY, SOLUTION IN SINGLE-DOSE CONTAINER naloxone READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, pharmacist or nurse. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Nyxoid is and what it is used for 2. What you need to know before you receive Nyxoid 3. How Nyxoid is to be given 4. Possible side effects 5. How to store Nyxoid 6. Contents of the pack and other information 1. WHAT NYXOID IS AND WHAT IT IS USED FOR This medicine contains the active substance naloxone. Naloxone temporarily reverses the effects of opioids such as heroin, methadone, fentanyl, oxycodone, buprenorphine and morphine. Nyxoid is a nasal spray used for the emergency treatment of opioid overdose or possible opioid overdose in adults and adolescents over 14 years. Signs of overdose include: • breathing problems • severe sleepiness • not responding to a loud noise or touch. IF YOU ARE AT RISK OF AN OPIOID OVERDOSE YOU SHOULD ALWAYS CARRY YOUR NYXOID WITH YOU . Nyxoid works for a short time only to reverse the effects of opioids while you wait for emergency medical attention. It is not a substitute for emergency medical care. Nyxoid is intended for use by appropriately trained individuals. Always tell your friends and family that you carry Nyxoid with you. 2. WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE NYXOID _ _ DO NOT USE NYXOID If you are allergic to naloxone or any of the other ingredients of this medicine (listed in section 6). WARNINGS AND PRECAUTIONS Nyxoid will be supplied to you only Lesen Sie das vollständige Dokument
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Nyxoid 1.8 mg nasal spray, solution in single-dose container 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each nasal spray container delivers 1.8 mg of naloxone (as hydrochloride dihydrate). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Nasal spray, solution in single-dose container (nasal spray) Clear, colourless to pale yellow solution 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Nyxoid is intended for immediate administration as emergency therapy for known or suspected opioid overdose as manifested by respiratory and/or central nervous system depression in both non-medical and healthcare settings. Nyxoid is indicated in adults and adolescents aged 14 years and over. Nyxoid is not a substitute for emergency medical care. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Adults and adolescents aged 14 years and over _ _ _ The recommended dose is 1.8 mg administered into one nostril (one nasal spray). In some cases, further doses may be necessary. The appropriate maximum dose of Nyxoid is situation specific. _ _ If the patient does not respond, the second dose should be administered after 2-3 minutes. If the patient responds to the first administration but then relapses again into respiratory depression, the second dose should be administered immediately. Further doses (if available) should be administered in alternate nostrils and the patient should be monitored whilst awaiting arrival of the emergency services. Emergency services may administer further doses according to local guidelines. _Paediatric population _ The safety and efficacy of Nyxoid in children below 14 years has not been established. No data are available. Method of administration Nasal use. Nyxoid should be administered as soon as possible to avoid damage to the central nervous system or death. 3 Nyxoid contains only one dose and therefore it must not be primed or tested prior to administration. Detailed instructions on how to use N Lesen Sie das vollständige Dokument